Skip to main content
Fig. 2 | BMC Medical Research Methodology

Fig. 2

From: Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan

Fig. 2

Comparing annual risk group specific incidence projections between NHSS, National-Model, and Jurisdictional-Model*. NHSS: National HIV Surveillance System; NHSS-National: national level estimates from NHSS; *Using period 2011 to 2019 to validate that National-Model simulated estimates are within range of NHSS estimates; using period 2018 to 2019 to verify that Jurisdictional-Model simulated estimates (from scenarios S1 to S4 , and S9 to S12) generate incidence in magnitudes similar to National-Model estimates; and using period 2020 to 2030 to observe differences between Jurisdictional-Model scenarios S1, S2, S3, S4, S9, S10, S11, and S12. Scenarios S5, S6, S7, and S8, start at the same baseline (2018) as S1, S2, S3, and S4, respectively. Scenarios S13, S14, S15, and S16, start at the same baseline (2018) as S9, S10, S11, and S12, respectively

Back to article page